SUSTAINED-RELEASE PRODUCT CANDIDATE FOR DRY EYE DISEASE
OTX-CSI is a long-acting, preservative-free cyclosporine intracanalicular insert being evaluated for the treatment of dry eye disease.1
EXISTING TREATMENTS
Slow onset of action for therapy2,3
High level of burning and stinging upon administration2,4
Burden of patient administration2,4
PRODUCT CANDIDATE ATTRIBUTES5
Cyclosporine loaded in hydrogel
Preservative-free
Designed to deliver therapy up to 12 weeks with a single insert
Occludes the punctum
Fully biodegradable insert
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling